Dexcom Announces Upcoming Conference Presentation
November 22 2022 - 9:00AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Matt Dolan,
Executive Vice President, Strategy, Corporate Development and
Dexcom Labs, will present an update on the company at the Piper
Sandler 34th Annual Healthcare Conference on Wednesday, November
30, 2022 at 8:30am (EST).
Links to the webcast will be available on the Dexcom Investor
Relations website at investors.dexcom.com and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of
diabetes through innovative continuous glucose monitoring (CGM)
systems. Headquartered in San Diego, California, and with
operations across Europe and select parts of Asia/Oceania, Dexcom
has emerged as a leader of diabetes care technology. By listening
to the needs of users, caregivers, and providers, Dexcom simplifies
and improves diabetes management around the world. For more
information about Dexcom CGM, visit www.dexcom.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221122005202/en/
DexCom, Inc. Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jun 2024 to Jul 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jul 2023 to Jul 2024